Big Pharma has so much money, they don't just buy politicians — they rent both parties. That's not a conspiracy theory. That's a quote from RFK Jr., and it's exactly what Republican strategist Chris Faulkner breaks down in this episode of Bust Big Pharma.

Rob Burgess sits down with Chris — a veteran political consultant who joined the Bust Big Pharma bus tour across the Southeast — to talk about why Congress won't act on drug pricing, what the 2026 midterms mean for pharma reform, and how everyday Americans can actually move the needle.

In this episode:

• Why Congress hesitates to codify Most Favored Nation pricing — and what's really behind the resistance
• How pharmaceutical companies spend 70–80% of ad dollars on some TV networks, and what that means for the news you're watching
• The three polling numbers every voter should know: 80%, 75%, 72%
• Why drug pricing is the ultimate 2026 wedge issue — and how candidates should be talking about it
• What a Republican strategist tells his clients about running against Big Pharma
• The Bernie Sanders moment that exposed Novo Nordisk's profit margin in real time
• Why dumping pharma stocks publicly might be the most effective form of civic activism right now

The bottom line: This isn't a left issue or a right issue. When 80% of Americans support Most Favored Nation pricing and 72% say they'd vote against a candidate who takes pharma money, you're not in ideological territory anymore. You're in mandate territory.

🔔 Subscribe for new episodes every week. 🌐 Learn more at BustBigPharma.com 📧 Seen a news story pharma doesn't want covered? Email us: truth@bustbigpharma.com